Investigators apply contact lens technologies to tackle myopia progression

Article

Recent commercial advances in contact lens optics have centered primarily on presbyopia correction, but the control of myopia progression with novel CL designs potentially represents an even bigger consumer market.

"Research investigating different methodologies to control myopia progression by manipulating optics has been ongoing for 2 decades or longer. However, there has been a recent resurgence of interest in this area as a result of the primate work by Smith and colleagues (2005, 2007)," said Dr. Kollbaum, assistant professor, Indiana University School of Optometry, Bloomington.

Dr. Kollbaum told Optometry Times, "The outcome of these studies is that the peripheral retina may be more responsible for the regulation of eye growth than previously thought. This finding has lead to several studies evaluating potential CL technologies and even the manufacture of a commercially available soft CL in Asia (CooperVision MiSight) designed to slow myopic progression."

There have been several anecdotal reports of some success with multi-zone or bifocal CLs in controlling myopic progression. In one such report, Aller and Wildsoet reported on a pair of identical twins with near esophoria in which use of bifocal CLs in one twin reduced myopia progression by roughly 1 D in 1 year.1

This approach is based on the theory that reduction of near esophoria increases accommodative accuracy, leading to decreased lag of accommodation, decreased hyperopic defocus, and ultimately a reduced stimulus for ocular growth, he explained.

In a larger unpublished, prospective, 12-month, double-masked, randomized, controlled study with 78 subjects aged 8 to 18 years, Aller et al. (2006) achieved similarly promising results with bifocal soft CLs. Compared with the control subjects wearing single vision soft CLs, the subjects fitted with bifocal soft CLs had roughly 0.5 D less increase in refractive error and almost 0.2 mm less increase in axial length. Data from a subset of 47 of these patients wearing the bifocal soft CLs followed for an additional 2 years showed only minimal change in refraction (<0.25 D) and axial length (<0.1 mm) over the longer follow-up.

Playing with design

Other optical approaches aimed at reducing myopia progression are designed to optimally correct vision within the central pupil while also moving the peripheral image from behind the retina onto or in front of it.

One series of such designs from Holden, Ho, Sankaridurg, Aller, and Smith (US 2007/0296916) provides optical correction for distance within a central zone that is approximately the size of the pupil and has a higher-power peripheral zone that curves or shifts the focus of the oblique rays forward onto or in front of the peripheral retina. This technology has been licensed to CIBA Vision for use in CLs and to Zeiss for use in spectacle lenses (MyoVision).

"Zeiss reports that a study of the spectacle lenses at Sun Yet-Sen University, in China, found this design reduced myopia progression by 30% in a series of young children," Dr. Kollbaum said.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Rhue and Canto-Sims talk the value of contact lens patients, financial insights, and key benefits of implementing a contact lens management system.
Eva Kim, MD, shares visual outcomes of EVO implantable collamer lens in patients with low to moderate myopia
Drs Brianna Rhue and Diana Canto-Sims discuss the benefits of implementing a contact lens management system that can help improve lens sales at your practice.
Dr Ashley Wallace Tucker speaks on the Myopia Management Navigator.
Matt Jones, OD; Matt Burns, OD; and Joe Sugg, OD; detailed what optometrists can expect to change when HB 1353's regulations are enacted later this year.
Arkansas Optometric Association legislative cochairs Matt Jones, OD; Matt Burns, OD; and Joe Sugg, OD, discuss their involvement in their bill and provide context for its relevance.
Elise Kramer, OD, FAAO, FSLS, describes her take on a multidisciplinary approach to dry eye
Dana Shannon, OD, FAAO, shares pearls on spotting red flags in need of referral and enhancing patient care with follow-up compliance.
Dana Shannon, OD, FAAO, detailed a lecture she gave at the NOA Midwestern Symposium earlier this month.
CRU 2025 provided the latest insights regarding glaucoma, dry eye disease, retina, myopia, neurotrophic keratitis, and keratoconus.
© 2025 MJH Life Sciences

All rights reserved.